November 5, 2011 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Protalix BioTherapeutics, Inc., a stock transaction, valued at $1,104.81. The trade took place on November 5, 2011 and was disclosed on May 15, 2012 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.